EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT01040832 · COMPLETED
Trial details
- NCT number
- NCT01040832
- Sponsor
- EMD Serono
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2012-01-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.